carotenoids Not classified
No linked studies yet.
$38.99 $1.29 per serving
Product analysis
Visibili-T contains lutein, which may help with selected aspects of contrast and glare. The ginkgo preparation is not fully identified, making its tentative attention benefits harder to predict.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality34
Chromium is clearly identified as chromium polynicotinate, while several other forms are unspecified. Named plant compounds do not establish the quality of the full mixture.
Ingredient Transparency67
Amounts are stated throughout, and several plant components are named. Some forms and the ginkgo component breakdown remain unspecified.
Value For Money34
The cost is high for the vitamin A and lycopene provided, with limited value in the chromium comparison. Value for the other main ingredients remains uncertain.
Customer Satisfaction75
Customer feedback is very positive. A moderate number of ratings adds context without establishing eye or cognitive benefits.
Product Focus59
The clearest connection is lutein support for selected contrast and glare-related functions. Ginkgo findings for attention are inconsistent and do not establish sustained memory improvement.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $1.29
- Customer rating
- 4.5 · 664 ratings
Goals
Impact
High effect
Vitamin A · 5000 IU
Lutein contributes to macular pigment and may support selected contrast and glare-related aspects of vision. The supplied studies found limited visual-performance benefits rather than consistent improvements in visual acuity, and the serving amount does not establish a daily study regimen.
How this product is rated for Eye Health
Ingredient fit62
Declared lutein gives the formula a direct connection to limited visual-performance support.
Goal fit
The broader formula includes ingredients outside vision support, reducing its focus on this goal.
Dose adequacy
Vitamin A has unresolved amount information, limiting the amount assessment.
Pathways80
The strongest assigned contribution is macular pigment and blue-light filtering. Lutein supports the macular-pigment category.
Depth
The strongest assigned contribution concerns macular pigment and blue-light filtering, without itself establishing a clinical vision benefit.
Breadth
The assigned coverage reaches the comparison threshold for macular pigment and blue-light filtering, ocular microcirculation.
Evidence100
Lutein leads the saved evidence finding. Lutein evidence concerns selected contrast and glare outcomes, with limited acuity findings.
Evidence strength
Lutein leads the recognized evidence contribution, subject to its population and outcome limitations.
Studied preparation
The counted preparations receive recognition in the saved comparison; that does not establish results for this finished product.
Formulation logic92
Unresolved ingredient amounts limit the formulation assessment; no ingredient conflict or unmet partner requirement was identified.
Partner coverage
No unmet partner requirement was identified for the counted ingredients.
Conflicts
No ingredient conflict was identified in the supplied findings.
Effective doses
Vitamin A does not meet the saved amount threshold; the other counted ingredients do.
Impact
Moderate effect
The 120 mg ginkgo amount is the relevant connection to cognition research. The supplied large long-term study did not show slower cognitive decline, so the ingredient offers a limited basis for routine brain-health expectations.
How this product is rated for Brain Health
Ingredient fit58
The saved findings identify 1 relevant ingredients and 8 other active ingredients (Carrot, Chromium, Grape, Lutein, Lycopene, Vitamin A, Zeaxanthin, bilberry). The saved findings show strong alignment of disclosed amounts with the comparison amounts.
Goal fit
The saved findings identify 1 relevant ingredients and 8 other active ingredients (Carrot, Chromium, Grape, Lutein, Lycopene, Vitamin A, Zeaxanthin, bilberry).
Dose adequacy
The saved findings show strong alignment of disclosed amounts with the comparison amounts.
Pathways43
The strongest identified area is Cerebral energy metabolism. 1 of 3 areas reach the saved coverage threshold: Cerebral energy metabolism.
Depth
The strongest identified area is Cerebral energy metabolism.
Breadth
1 of 3 areas reach the saved coverage threshold: Cerebral energy metabolism.
Evidence58
Ginkgo provides the strongest eligible evidence contribution in the saved findings. The saved findings match the eligible preparations to studied preparations.
Evidence strength
Ginkgo provides the strongest eligible evidence contribution in the saved findings.
Studied preparation
The saved findings match the eligible preparations to studied preparations.
Formulation logic100
The assessed ingredients can work alone or have their identified partner present. No matched ingredient conflict was recorded. 1 of 1 assessed ingredients reach the saved minimum comparison amount.
Partner coverage
The assessed ingredients can work alone or have their identified partner present.
Conflicts
No matched ingredient conflict was recorded.
Effective doses
1 of 1 assessed ingredients reach the saved minimum comparison amount.
Impact
Moderate effect
Ginkgo at 120 mg has a limited connection to acute attention speed and cerebral blood flow. The preparation is unidentified, which limits how directly specific extract findings apply; sustained memory improvement is not established by those acute findings.
How this product is rated for Cognitive Support
Ingredient fit58
The saved assessment identifies 1 relevant ingredients and 8 other active ingredients. The formula is linked to 8 goals. The saved amount assessment is strong overall. Unknown individual amounts reduce confidence in the contribution.
Goal fit
The saved assessment identifies 1 relevant ingredients and 8 other active ingredients. The formula is linked to 8 goals.
Dose adequacy
The saved amount assessment is strong overall. Unknown individual amounts reduce confidence in the contribution.
Pathways40
Cerebral blood flow is the strongest represented mechanism, with meaningful coverage in the saved findings. 1 of the three assessed mechanism targets reaches the saved coverage threshold.
Depth
Cerebral blood flow is the strongest represented mechanism, with meaningful coverage in the saved findings.
Breadth
1 of the three assessed mechanism targets reaches the saved coverage threshold.
Evidence25
Ginkgo provides the strongest evidence among the ingredients meeting the saved amount threshold. Evidence remains limited to the outcomes and populations described for that ingredient. The saved assessment does not match Ginkgo to the studied preparations.
Evidence strength
Ginkgo provides the strongest evidence among the ingredients meeting the saved amount threshold. Evidence remains limited to the outcomes and populations described for that ingredient.
Studied preparation
The saved assessment does not match Ginkgo to the studied preparations.
Formulation logic100
The assessed ingredients can contribute alone or have their required partner present. No configured ingredient conflict was identified in the supplied assessment. 1 of 1 assessed ingredients meet the saved minimum amount threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partner present.
Conflicts
No configured ingredient conflict was identified in the supplied assessment.
Effective doses
1 of 1 assessed ingredients meet the saved minimum amount threshold.
Impact
Moderate effect
Lycopene · 2 mg
Lutein-containing carotenoids may help support skin responses to oxidative stress from UV exposure, with limited evidence from small trials involving skin tone, hydration and elasticity. The separately assessed carotenoid finding is the main skin contribution here; 2 mg lycopene is below the amounts used in the supplied skin trials. These findings do not imply sunscreen-like protection.
How this product is rated for Skin Health
Ingredient fit50
2 ingredients relate to the assessed skin goal, alongside 5 other actives, so the formula has a broader focus. The assessed amounts partly align with the saved dose comparisons.
Goal fit
2 ingredients relate to the assessed skin goal, alongside 5 other actives, so the formula has a broader focus.
Dose adequacy
The assessed amounts partly align with the saved dose comparisons.
Pathways45
The strongest saved connection is uv antioxidant defence, with partial support at the declared amounts. UV antioxidant support reaches the saved coverage threshold; the other skin pathways remain limited.
Depth
The strongest saved connection is uv antioxidant defence, with partial support at the declared amounts.
Breadth
UV antioxidant support reaches the saved coverage threshold; the other skin pathways remain limited.
Evidence67
Lutein, zeaxanthin and mixed carotenoids leads the saved evidence assessment among ingredients with sufficient assessed amounts. Evidence strength varies by ingredient and does not predict an individual benefit. The saved assessment identifies 1 ingredient preparations as matching its evidence criteria at sufficient assessed amounts.
Evidence strength
Lutein, zeaxanthin and mixed carotenoids leads the saved evidence assessment among ingredients with sufficient assessed amounts. Evidence strength varies by ingredient and does not predict an individual benefit.
Studied preparation
The saved assessment identifies 1 ingredient preparations as matching its evidence criteria at sufficient assessed amounts.
Formulation logic88
The assessed ingredients can contribute on their own or have their required partner present. 1 of 2 assessed ingredients meet the saved minimum amount threshold. Vitamin A fall below that threshold.
Partner coverage
The assessed ingredients can contribute on their own or have their required partner present.
Conflicts
No ingredient conflict was identified in the saved assessment.
Effective doses
1 of 2 assessed ingredients meet the saved minimum amount threshold. Vitamin A fall below that threshold.
Impact
Moderate effect
Ginkgo at 120 mg provides the main relevance to mental focus. Its cognitive evidence includes selected acute findings but inconsistent attention benefits, so the contribution remains tentative.
How this product is rated for Mental Focus
Ingredient fit58
Ginkgo provides focus-related relevance within a formula largely aimed at other purposes. The 120 mg ginkgo amount reaches the saved exposure comparison level.
Goal fit
Ginkgo provides focus-related relevance within a formula largely aimed at other purposes.
Dose adequacy
The 120 mg ginkgo amount reaches the saved exposure comparison level.
Pathways44
Brain energy supply is the main assessed route. Only brain energy supply reaches the saved coverage level.
Depth
Brain energy supply is the main assessed route.
Breadth
Only brain energy supply reaches the saved coverage level.
Evidence62
Ginkgo provides the strongest saved evidence contribution at a counted amount; the scope and limitations of its evidence still apply. Ginkgo matches the preparation category accepted in the saved assessment.
Evidence strength
Ginkgo provides the strongest saved evidence contribution at a counted amount; the scope and limitations of its evidence still apply.
Studied preparation
Ginkgo matches the preparation category accepted in the saved assessment.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. The counted ingredient meets the saved minimum exposure comparison.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the saved assessment.
Effective doses
The counted ingredient meets the saved minimum exposure comparison.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin A (Beta-Carotene) | 5000 IU | |
Chromium (Chromium Polynicotinate) | 400 mcg | |
Carrot | 150 mg | |
Ginkgo biloba leaf extract (Flavone Glycosides, Terpene Lactones) | 120 mg | |
Grape seed extract (Polyphenols) | 100 mg | |
Bilberry fruit extract (Anthocyanins) | 50 mg | |
Lutein | 20 mg | |
Zeaxanthin | 3 mg | |
Lycopene | 2 mg |
Chromium (Chromium Polynicotinate) · 400 mcg OverallScore70
Each serving supplies 400 mcg of chromium; its cost per 200 mcg is moderately high. It uses chromium polynicotinate. No branded chromium source is identified in the available information.
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
It uses chromium polynicotinate. No branded chromium source is identified in the available information.
Chromium Chemical Form
It uses chromium polynicotinate.
Branded & Trademarked Sources
No branded chromium source is identified in the available information.
Dose, Safety & Label Transparency85
The serving lists 400 mcg of chromium. A separate compound weight is not available.
Elemental Chromium Dosage
Each serving supplies 400 mcg of chromium.
Label Transparency & Disclosure
The chromium amount is stated, but a separate source compound weight is not available.
Value40
The cost per 200 mcg of chromium is moderately high.
Price per 200 mcg Chromium
The cost per 200 mcg of chromium is moderately high.
Vitamin A (Beta-Carotene) · 5000 IU OverallScore57
Each serving provides 5,000 IU of vitamin A. The cost for that amount is high. Vitamin A comes from beta-carotene.
How this ingredient is rated
Active Ingredient Quality & Bioavailability50
Vitamin A comes from beta-carotene.
Vitamin A Chemical Form & Source
Vitamin A comes from beta-carotene.
Dose, Safety & Label Transparency82
Each serving provides 5,000 IU of vitamin A. The vitamin A source is named as beta-carotene.
Dosage Efficacy & Safety Thresholds
Each serving provides 5,000 IU of vitamin A.
Label Transparency of Specific Forms
The vitamin A source is named as beta-carotene.
Value20
The cost is high for the amount of vitamin A provided.
Price per 5,000 IU Dose
The cost is high for the amount of vitamin A provided.
Ginkgo (Flavone Glycosides, Terpene Lactones) · 120 mg OverallScore85
The serving supplies 120 mg of ginkgo. The source is Ginkgo Leaf Extract. The extract specifies 24% flavones and 6% terpenes. No ginkgolic acid limit is available, so its level is unclear. Value cannot be assessed from the available criteria.
How this ingredient is rated
Composition and Label Disclosure70
The extract specifies 24% flavones and 6% terpenes. No ginkgolic acid limit is available, so its level is unclear.
Marker and Preparation Disclosure
The extract specifies 24% flavones and 6% terpenes.
Declared Ginkgolic Acid Limit
No ginkgolic acid limit is available, so its level is unclear.
Composition and Label Disclosure100
The serving states 120 mg of ginkgo as Ginkgo Leaf Extract.
Individual Preparation Amount Disclosure
The serving states 120 mg of ginkgo and names Ginkgo Leaf Extract.
Commercial Price and Usability
Value was not assessed.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- The Associations of Plasma Carotenoids and Vitamins With Risk of Age-Related Macular Degeneration: Results From a Matched Case-Control Study in China and Meta-Analysis.
- Serum carotenoids and risk of age-related macular degeneration in a chinese population sample.
- Serum antioxidants and age-related macular degeneration in a population-based case-control study.
- Association between serum carotenoid concentrations and risk of major age-related eye diseases among middle-aged and older adults.
- Plasma antioxidant vitamins and carotenoids and age-related cataract
- A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.